Wishing you all the joys of the season! 
North America Pharmaceutical Contract Sales Organizations Market Forecast to 2030
North America Pharmaceutical Contract Sales Organizations Market Forecast to 2030 – Regional Analysis – by Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), and End User (Biopharmaceutical Companies and Pharmaceutical Companies)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Increasing Integration of Digital Technologies Drives North America Pharmaceutical Contract Sales Organizations Market
The increased deployment of digital technologies fuels a transformational surge in the pharmaceutical contract sales organization (CSO) market. This fundamental change highlights the need for a tactical response to the dynamically changing pharmaceutical market. An essential component of streamlining sales operations, increasing productivity, and navigating the complexities of a healthcare environment that is becoming increasingly digitized is integrating digital tools and technologies into CSOs. With advanced customer relationship management tools, artificial intelligence, and data analytics, CSOs can gain valuable insights, customize their sales strategies, and establish deeper relationships with healthcare professionals. In addition to speeding up information transmission, the seamless integration of digital platforms allows for real-time adaptability to market trends and legislative changes. This technological change in the pharmaceutical CSO landscape represents more than just a fad; it represents a fundamental redefining of how sales tactics are developed and implemented. The adoption of digital technologies places CSOs at the forefront of innovation. It promotes a more responsive environment that aligns with the larger digital transformation sweeping the healthcare sector. The market is positioned for sustained growth as pharmaceutical CSOs continue to use the power of digitalization, propelled by a convergence of technological expertise, strategic agility, and a clear awareness of the contemporary demands of the pharmaceutical ecosystem.
North America Pharmaceutical Contract Sales Organizations Market Overview
The pharmaceutical contract sales organizations market in North America is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period. The pharmaceutical contract sales organizations market in North America is expected to grow due to the adoption of new technologies by contract sales organizations, the surging emphasis of pharmaceutical companies in boosting the sales of small-molecule and biopharmaceutical drugs, and an increase in focus on cutting down the costs incurred by in-house sales operations are the major factors driving the growth of the pharmaceutical contract sales organizations market in North America. The number of launches of new medicine has spiked over time. According to a report by IQVIA on R&D trends, 84 new active compounds were introduced globally in 2021, twice as many as introduced in the previous 5 years. The demand for contract sales services is anticipated to rise with the increase in drug releases internationally. North America accounts for the largest share of the pharmaceutical contract sales organization market. Key players such as EPS Corp.; IQVIA, Inc.; and Axxelus fuel the market in this region.
North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)
North America Pharmaceutical Contract Sales Organizations Market Segmentation
The North America pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.
Based on services, the North America pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.
Based on modules, the North America pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.
Based on therapeutic area, the North America pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the North America pharmaceutical contract sales organizations market in 2022.
Based on end user, the North America pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.
Based on country, the North America pharmaceutical contract sales organizations market is segmented into the US, Canada, and Mexico. The US dominated the North America pharmaceutical contract sales organizations market in 2022.
Aenova Holding GmbH, Axxelus Inc, CMIC Holdings Co Ltd, IQVIA Holdings Inc, Peak Pharma Solutions Inc, Pfizer Inc, Promoveo Health LLC, QFR Solutions LLC, Sales Focus Inc, and Syneos Health Inc are some of the leading companies operating in the North America pharmaceutical contract sales organizations market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the North America pharmaceutical contract sales organizations market was valued at US$ 3,987.29 million in 2022 and is expected to reach US$ 7,614.12 million by 2030, registering a CAGR of 8.4% from 2022 to 2030. Increasing integration of digital technologies and expansion in emerging markets are among the critical factors attributed to the North America pharmaceutical contract sales organizations market expansion.
The future trajectory of the pharmaceutical contract sales organization (CSO) market is distinctly shaped by the strategic trend of expanding into emerging markets. As the global pharmaceutical landscape increases, emerging economies gain prominence, CSOs increasingly recognize the untapped potential in these regions. Emerging markets present opportunities driven by rising healthcare awareness, expanding middle-class populations, and increasing government investments in healthcare infrastructure. By extending their operations into these burgeoning markets, CSOs can capitalize on the growing demand for pharmaceutical products and establish a strong foothold early in markets poised for substantial growth. However, this expansion necessitates a wise understanding of local regulatory landscapes, cultural nuances, and diverse healthcare systems. Successful expansion into emerging markets demands a tailored approach, where CSOs must align their strategies with each region’s unique challenges and opportunities. Furthermore, such expansions position CSOs as crucial players in the global healthcare ecosystem, contributing to revenue growth and the broader goal of improving healthcare accessibility and outcomes in these evolving markets. In essence, the strategic move toward expanding in emerging markets emerges as a forward-looking trend, reflecting the adaptability and foresight of pharmaceutical CSOs in navigating the complexities of a globalized pharmaceutical landscape.
On the contrary, quality issues associated with outsourcing hamper the North America pharmaceutical contract sales organizations market.
Based on services, the North America pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held 73.1% share of North America pharmaceutical contract sales organizations market in 2022, amassing US$ 2,913.05 million. It is projected to garner US$ 5,776.36 million by 2030 to expand at 8.9% CAGR during 2022-2030.
Based on modules, the North America pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held 51.8% share of North America pharmaceutical contract sales organizations market in 2022, amassing US$ 2,065.62 million. It is projected to garner US$ 4,208.48 million by 2030 to expand at 9.3% CAGR during 2022-2030.
Based on therapeutic area, the North America pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held 34.8% share of North America pharmaceutical contract sales organizations market in 2022, amassing US$ 1,388.87 million. It is projected to garner US$ 2,988.65 million by 2030 to expand at 10.1% CAGR during 2022-2030.
Based on end user, the North America pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held 59.4% share of North America pharmaceutical contract sales organizations market in 2022, amassing US$ 2,367.34 million. It is projected to garner US$ 4,385.02 million by 2030 to expand at 8.0% CAGR during 2022-2030.
Based on country, the North America pharmaceutical contract sales organizations market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 83.8% share of North America pharmaceutical contract sales organizations market in 2022. It was assessed at US$ 3,340.67 million in 2022 and is likely to hit US$ 6,560.35 million by 2030, exhibiting a CAGR of 8.8% during 2022-2030.
Key players operating in the North America pharmaceutical contract sales organizations market are Aenova Holding GmbH, Axxelus Inc, CMIC Holdings Co Ltd, IQVIA Holdings Inc, Peak Pharma Solutions Inc, Pfizer Inc, Promoveo Health LLC, QFR Solutions LLC, Sales Focus Inc, and Syneos Health Inc, among others.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the North America Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Pharmaceutical Contract Sales Organizations Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
5. North America Pharmaceutical Contract Sales Organizations Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Integration of Digital Technologies
5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:
6. Pharmaceutical Contract Sales Organizations Market – North America Market Analysis
6.1 North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 – 2030
7. North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 – by Services
7.1 Overview
7.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
7.3.1 Overview
7.3.2 Commercial Services: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
7.4.1 Overview
7.4.2 Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 – by Modules
8.1 Overview
8.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
8.3.1 Overview
8.3.2 Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
8.4.1 Overview
8.4.2 Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 – by Therapeutic Area
9.1 Overview
9.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
9.3.1 Overview
9.3.2 Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
9.5.1 Overview
9.5.2 Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
9.6.1 Overview
9.6.2 Neurology: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
9.7.1 Overview
9.7.2 Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
9.8.1 Overview
9.8.2 Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
10.3.1 Overview
10.3.2 Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
11. North America Pharmaceutical Contract Sales Organizations Market – Country Analysis
11.1 North America
11.1.1.1 North America Pharmaceutical Contract Sales Organizations Market, by Country
11.1.1.2 US
11.1.1.2.1 US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.2 US: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.2.3 US: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.2.4 US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.2.5 US: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 Canada
11.1.1.3.1 Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.2 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.3.3 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.3.4 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.3.5 Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.4 Mexico
11.1.1.4.1 Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.4.3 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.4.4 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.4.5 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
12. Pharmaceutical Contract Sales Organizations Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 CMIC Holdings Co Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Axxelus Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 IQVIA Holdings Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Peak Pharma Solutions Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 QFR Solutions LLC
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Promoveo Health LLC
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Syneos Health Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Aenova Holding GmbH
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Pfizer Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Sales Focus Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation
Table 2. US: North America Pharmaceutical Contract Sales Organizations Market, by Services – Revenue and Forecast to 2030 (US$ Million)
Table 3. US: North America Pharmaceutical Contract Sales Organizations Market, by Modules – Revenue and Forecast to 2030 (US$ Million)
Table 4. US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 5. US: North America Pharmaceutical Contract Sales Organizations Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 6. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services – Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules – Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 10. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services – Revenue and Forecast to 2030 (US$ Million)
Table 11. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules – Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 15. Glossary of Terms, North America Pharmaceutical Contract Sales Organizations Market
LIST OF FIGURES
Figure 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
Figure 2. North America – PEST Analysis
Figure 3. North America Pharmaceutical Contract Sales Organizations Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 – 2030
Figure 6. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
Figure 7. Commercial Services: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
Figure 10. Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
Figure 13. Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oncology: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Neurology: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 21. Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America Pharmaceutical Contract Sales Organizations Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24. North America Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
Figure 25. US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
The List of Companies – North America Pharmaceutical Contract Sales Organizations Market
1. Aenova Holding GmbH
2. Axxelus Inc
3. CMIC Holdings Co Ltd
4. IQVIA Holdings Inc
5. Peak Pharma Solutions Inc
6. Pfizer Inc
7. Promoveo Health LLC
8. QFR Solutions LLC
9. Sales Focus Inc
10. Syneos Health Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.